Humanin is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
Humanin (Humanin mitochondrial-derived peptide) is researched primarily for neuroprotection, Alzheimer's disease mitigation, cognitive preservation, anti-aging, metabolic health, mitochondrial restoration. One of only two known mitochondrial-encoded peptides with therapeutic potential (alongside MOTS-C), representing a completely new class of endogenous anti-aging factors that decline with age. It belongs to the Mitochondrial-derived peptide, cytoprotective factor category of compounds.
What Is Humanin?
Humanin (Humanin mitochondrial-derived peptide) is a Mitochondrial-derived peptide, cytoprotective factor. Endogenous 24-amino acid peptide encoded within mitochondrial DNA, released under stress conditions as a survival signal.
One of only two known mitochondrial-encoded peptides with therapeutic potential (alongside MOTS-C), representing a completely new class of endogenous anti-aging factors that decline with age. It has attracted significant research interest for its potential effects on neuroprotection, Alzheimer's disease mitigation, cognitive preservation, anti-aging, metabolic health, mitochondrial restoration.
How Does Humanin Produce These Benefits?
Stabilizes mitochondrial function and prevents mitochondrial dysfunction-induced neuronal death. Activates survival signaling through IGF-1R and MAPK pathways. Reduces oxidative stress and exerts anti-inflammatory effects by reducing pro-inflammatory cytokine production. Specifically protects against Aβ42-induced neuronal damage in Alzheimer's models.
This multi-pathway activity is why Humanin shows potential across several different applications rather than being limited to a single use case.
Can Humanin Help With Neuroprotection?
Research suggests Humanin may support neuroprotection through its mitochondrial-derived peptide, cytoprotective factor activity. Humanin analogs show neuroprotection in Alzheimer's models, synapse preservation, and cognitive improvements in aging mice. Reduced inflammatory markers and improved metabolic healthspan in treated animals. Zero human clinical trials completed. Phase II studies planned.
Protocols targeting neuroprotection typically use 2.5 mg/kg (animal studies); human dosing not established administered twice daily in animal protocols for human protocol undefined; chronic dosing in animal models.
Can Humanin Help With Alzheimer'S Disease Mitigation?
Research suggests Humanin may support Alzheimer's disease mitigation through its mitochondrial-derived peptide, cytoprotective factor activity. Humanin analogs show neuroprotection in Alzheimer's models, synapse preservation, and cognitive improvements in aging mice. Reduced inflammatory markers and improved metabolic healthspan in treated animals. Zero human clinical trials completed. Phase II studies planned.
Protocols targeting Alzheimer's disease mitigation typically use 2.5 mg/kg (animal studies); human dosing not established administered twice daily in animal protocols for human protocol undefined; chronic dosing in animal models.
Can Humanin Help With Cognitive Preservation?
Research suggests Humanin may support cognitive preservation through its mitochondrial-derived peptide, cytoprotective factor activity. Humanin analogs show neuroprotection in Alzheimer's models, synapse preservation, and cognitive improvements in aging mice. Reduced inflammatory markers and improved metabolic healthspan in treated animals. Zero human clinical trials completed. Phase II studies planned.
Protocols targeting cognitive preservation typically use 2.5 mg/kg (animal studies); human dosing not established administered twice daily in animal protocols for human protocol undefined; chronic dosing in animal models.
Can Humanin Help With Anti-Aging?
Research suggests Humanin may support anti-aging through its mitochondrial-derived peptide, cytoprotective factor activity. Humanin analogs show neuroprotection in Alzheimer's models, synapse preservation, and cognitive improvements in aging mice. Reduced inflammatory markers and improved metabolic healthspan in treated animals. Zero human clinical trials completed. Phase II studies planned.
Protocols targeting anti-aging typically use 2.5 mg/kg (animal studies); human dosing not established administered twice daily in animal protocols for human protocol undefined; chronic dosing in animal models.
Can Humanin Help With Metabolic Health?
Research suggests Humanin may support metabolic health through its mitochondrial-derived peptide, cytoprotective factor activity. Humanin analogs show neuroprotection in Alzheimer's models, synapse preservation, and cognitive improvements in aging mice. Reduced inflammatory markers and improved metabolic healthspan in treated animals. Zero human clinical trials completed. Phase II studies planned.
Protocols targeting metabolic health typically use 2.5 mg/kg (animal studies); human dosing not established administered twice daily in animal protocols for human protocol undefined; chronic dosing in animal models.
Can Stacking Enhance Humanin Benefits?
Pairs with MOTS-C (another mitochondrial-derived peptide) for comprehensive mitochondrial support, and with NAD+ precursors for cellular energy optimization.
See our Humanin stacking guide for detailed combination protocols.
What Is the Bottom Line on Humanin Benefits?
Humanin is researched for neuroprotection, Alzheimer's disease mitigation, cognitive preservation, anti-aging, metabolic health, mitochondrial restoration. The evidence base includes: Humanin analogs show neuroprotection in Alzheimer's models, synapse preservation, and cognitive improvements in aging mice. Reduced inflammatory markers and improved metabolic healthspan in treated animals. Zero human clinical trials completed. Phase II studies planned.
Humanin is not fda-approved. research peptide only. Source from reputable vendors with third-party testing for reliable results.
Complete Guide
Humanin: The Mitochondrial Peptide
Related Reading
- Humanin Dosage Guide
- Humanin Side Effects
- Humanin Stacking Guide
- Humanin Cycle Guide
- Humanin Research
- MOTS-C Complete Guide
Calculate Your Humanin Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Humanin.
Open Calculator →Research-Grade Sourcing
If you're going to research Humanin, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is Humanin?
Humanin (Humanin mitochondrial-derived peptide) is a Mitochondrial-derived peptide, cytoprotective factor. Endogenous 24-amino acid peptide encoded within mitochondrial DNA, released under stress conditions as a survival signal. It is researched for neuroprotection, Alzheimer's disease mitigation, cognitive preservation, anti-aging, metabolic health, mitochondrial restoration.
What is the recommended Humanin dosage?
Common dosages: 2.5 mg/kg (animal studies); human dosing not established administered twice daily in animal protocols via subcutaneous injection (proposed for humans). Cycle length: human protocol undefined; chronic dosing in animal models. Half-life: ~30 minutes in mice; >4 hours in rats. Use our peptide calculator for exact reconstitution math.
What are the side effects of Humanin?
No significant side effects in preclinical studies. Human safety data completely absent. Potential for antibody formation with chronic use.
Is Humanin safe?
Humanin has shown a preliminary safety profile in research. Not FDA-approved. Research peptide only. All research should follow appropriate safety protocols.